Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,036.00
Bid: 2,034.00
Ask: 2,038.00
Change: -24.00 (-1.17%)
Spread: 4.00 (0.197%)
Open: 2,068.00
High: 2,068.00
Low: 2,026.00
Prev. Close: 2,060.00
WEIR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

4 Dec 2007 07:02

Weir Group PLC04 December 2007 THE WEIR GROUP PLC 4 December 2007 TRADING UPDATE The Weir Group PLC today issues the following trading update in respect of the52 weeks ending 28 December 2007. In the second half, the Group's financial performance has been strong as aresult of better than expected revenue growth reflecting continued strong marketconditions across the mining, oil and gas and power sectors. Revenue for the 44 weeks to 2 November 2007 was 15% ahead on a like for likeconstant currency basis. Additionally, revenues of around £55m were recognisedby SPM for the 15 week post acquisition period to 2 November 2007. As a result, we now expect profit from continuing operations before tax,intangibles amortisation and exceptional items to be around the upper end ofcurrent Reuters market estimates. Divisional Trading Comment-------------------------- Engineering Products In the 18 week period to 2 November 2007, the Engineering Products Division(excluding SPM) has achieved good levels of growth in order input, revenue andprofit leading to continued improvement in underlying operating margins whencompared to 2006. The integration of SPM is proceeding well. Year to date revenue is ahead ofinitial expectations and we now expect revenue for calendar year 2007 to bearound $350m. Operating margin remains broadly in line with expectations asoutlined in our acquisition announcement. Engineering Services As anticipated, revenue for the 18 week period to 2 November 2007 is broadly inline with 2006. As a result of the 2006 restructurings undertaken in the MiddleEast, USA and UK profitability has, however, improved over the same period. Defence, Nuclear & Gas The Defence, Nuclear and Gas Division performed in line with expectations.Operating profit for the 18 week period to 2 November 2007 is consistent withthe prior year period. Outlook for 2008---------------- Further progress across all divisions is anticipated in 2008 as a result of thecontinuing level of input growth in 2007 and the inclusion of SPM for a fullyear. Footnote:1. The range of analysts' forecasts on Reuters Knowledge Consensus at 29November 2007 for Continuing Operations profit before tax, intangiblesamortisation and exceptional items was £105.5m to £114.5m with a consensus of£110.1m. 2. Like for like revenue growth refers to the comparison of current yearresults to the equivalent prior year period for those businesses that have beenpart of the Group throughout the current and prior year reporting period, on aconstant currency basis. 3. The Group expects to publish its preliminary results for the year ended 28December 2007 on 11 March 2008. Contact details: The Weir Group PLCMark Selway, Chief Executive Tel. 0141 637 7111 (switchboard);Helen Walker, Public Relations Manager Tel. 0141 308 3739 (Mobile: 07789 032296)Maitland Tel. 020 7379 5151Suzanne BartchPeter Ogden This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Jun 20245:24 pmRNSDirector/PDMR Shareholding
28th May 202412:03 pmRNSDirector/PDMR Shareholding
23rd May 20244:58 pmRNSDirector/PDMR Shareholding
15th May 20247:39 amRNSDirectorate Change
13th May 20249:54 amRNSHolding(s) in Company
25th Apr 20244:06 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Update
15th Apr 20245:21 pmRNSDirector/PDMR Shareholding
15th Apr 20244:28 pmRNSDirector/PDMR Shareholding
15th Apr 20244:19 pmRNSDirector/PDMR Shareholding
15th Apr 20244:18 pmRNSDirector/PDMR Shareholding
10th Apr 20243:18 pmRNSDirector/PDMR Shareholding
10th Apr 20242:14 pmRNSDirector/PDMR Shareholding
10th Apr 20242:11 pmRNSDirector/PDMR Shareholding
5th Apr 202411:30 amRNSHolding(s) in Company
21st Mar 202410:44 amRNS2023 Annual Report and 2024 Annual General Meeting
13th Mar 202410:31 amRNSWeir opens new foundry in China
7th Mar 202411:04 amRNSHolding(s) in Company
29th Feb 20247:00 amRNSFull Year Results
27th Feb 20249:47 amRNSDirectorate Change
7th Feb 20248:48 amRNSHolding(s) in Company
6th Feb 20248:13 amRNSWeir achieves ‘A’ score from CDP
31st Jan 20248:07 amRNSDirectorate Change
19th Dec 202310:29 amRNSNew Board Committee and Board Changes
6th Dec 20237:00 amRNSWeir announces 2026 operating margin target of 20%
5th Dec 20233:09 pmRNSDirectorate Change
4th Dec 20231:30 pmRNSWeir study on energy in mining
23rd Nov 20237:00 amRNSWeir acquires SentianAI
14th Nov 20239:54 amRNSDirector/PDMR Shareholding
7th Nov 20239:04 amRNSDirector/PDMR Shareholding
3rd Nov 20233:51 pmRNSHolding(s) in Company
3rd Nov 20233:51 pmRNSHolding(s) in Company
1st Nov 20237:01 amRNSAppointment of Chief Financial Officer
1st Nov 20237:00 amRNSQ3 Trading Update
26th Oct 20231:55 pmRNSHolding(s) in Company
24th Oct 20238:39 amRNSDirectorate Change
2nd Oct 20237:00 amRNSCapital Markets Event – 6 December 2023
18th Aug 20235:13 pmRNSDirector/PDMR Shareholding
18th Aug 20235:00 pmRNSHolding(s) in Company
18th Aug 20232:44 pmRNSDirector/PDMR Shareholding
18th Aug 20232:30 pmRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSHalf-year Report
31st Jul 20232:19 pmRNSTotal Voting Rights
28th Jul 20234:45 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSDirectorate change
27th Jul 20237:00 amRNSAppointment of John Heasley as Finance Director
13th Jul 202311:59 amRNSStabilisation Notice
30th Jun 20233:51 pmRNSTotal Voting Rights
14th Jun 20232:31 pmRNSHolding(s) in Company
12th Jun 20232:50 pmRNSDirector / PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.